Filetype
Professor Contact details Email: therese [dot] nilsson [at] nek [dot] lu [dot] se Phone: +46 46 222 46 43Organisation Department of Economics Room number: Alfa1:4101 Service point: 10 WebpageTherese Nilssons profile in Lund University research portalPersonal website:https://sites.google.com/site/nilssonltherese/homeOther affiliations Profile area member LU Profile Area: Proactive Ageing Affiliated
https://www.lusem.lu.se/therese-nilsson - 2026-07-03
Associate professor Contact details Email: finn [dot] hedefalk [at] ekh [dot] lu [dot] se Phone: +46 73 816 60 29 Mobile: +46 73 816 60 29Organisation Department of Economic History Visiting address: Scheelevägen 15B, Alfa 1, Lund Room number: Alfa1:2008 Service point: 10 WebpageFinn Hedefalks profile in Lund University research portalOther affiliations Researcher Centre for Economic Demography Pu
https://www.lusem.lu.se/finn-hedefalk - 2026-07-03
Associate professor Contact details Email: eduardo [dot] gill_pedro [at] jur [dot] lu [dot] se Phone: +46 46 222 12 17Organisation Department of Law Room number: 188 Service point: 56 WebpageEduardo Gill Pedros profile in Lund University research portalOther affiliations Researcher EU Law Senior lecturer Department of Law Publications Displaying of publications. Sorted by year, then title. Filter
https://www.law.lu.se/eduardo-gill-pedro - 2026-07-03
Affiliated Researcher Contact details Email: carys [dot] egan-wyer [at] fek [dot] lu [dot] seOrganisation Marketing Service point: 10 WebpageCarys Egan-Wyers profile in Lund University research portalOther affiliations Affiliated researcher Centre for Retail and Logistics (REAL) Publications Displaying of publications. Sorted by year, then title. Filter by type AllAbstractAnthology (editor)Article
https://www.real.lu.se/en/carys-egan-wyer - 2026-07-03
FÖRSÄTTSSIDA STYRDOKUMENT Riktlinjer för vidaredelegationer vid Juridiska fakulteten vid Lunds universitet Typ av styrdokument: Riktlinjer Beslutsfattare: Juridiska fakultetsstyrelsen Beslutsdatum: 2025-06-19 Diarienummer: STYR 2025/1440 Ikraftträdande: 2025-06-19 Giltighetstid: Löpande Ansvarig organisatorisk enhet: Juridiska fakultetsstyrelsen Ansvarig handläggare: Kanslichef Kort beskrivning: D
Senior lecturer Contact details Email: carys [dot] egan-wyer [at] fek [dot] lu [dot] seOrganisation Marketing Service point: 10 WebpageCarys Egan-Wyers profile in Lund University research portalOther affiliations Affiliated researcher Centre for Retail and Logistics (REAL) Publications Displaying of publications. Sorted by year, then title. Filter by type AllAbstractAnthology (editor)ArticleBookBo
https://www.lusem.lu.se/carys-egan-wyer - 2026-07-03
Popular Abstract in Swedish I en alltmer konkurrenskraftig omvärld är det av störst vikt att i ett högkostnadsland som Sverige att innovera och utveckla produkter så effektivt som möjligt. För att uppnå dessa mål finns det klara indikationer på att våra nuvarande produktutvecklings- och konstruktionstillvägagångssätt saknar väsentliga egenskaper för att uppnå önskvärd effektivitet. Den frekvent mIn an industrial context when the product development cycles are shortened and constraints on technical innovations are high, it is very important to provide a very efficient and effective engineering design activity. In the current engineering design literature, most methodologies are by and large based on the so-called systematic engineering design approach. This approach is characterized by an
Optical spectroscopy has been used as a supplement to conventional techniques for analyzing and diagnosing cancer in many human organs. Because ocular tumors may be characterized by their different melanin content, we investigated the feasibility of using transscleral visible/near-infrared spectroscopy (Vis/NIRS) to estimate the quantity of melanin in a novel uveal melanoma phantom of ex vivo porc
Context Inpatients with nonvalvular atrial fibrillation, warfarin prevents ischemic stroke, but dose adjustment, coagulation monitoring, and bleeding limit its use. Objective To compare the efficacy of the oral direct thrombin inhibitor ximelagatran with warfarin for prevention of stroke and systemic embolism. Design, Setting, and Participants Double-blind, randomized, multicenter trial (20002001)
When a child is diagnosed with diabetes, the symptoms may be in its most severe form with ketoacidosis, to mild symptoms of diabetes, detected incidentally. Moderate and severe symptoms of diabetes presentation require infusion therapy and thereby necessitate hospitalisation for the first few days. The initial management is largely a preparation for family members to help them gain the practical u
Bacterial abundance and production were studied in different zones in the Southern Ocean (39-62degreesS, 4-14degreesE) during a cruise in December-January 1997/1998. The role of potential growth limitation of bacteria due to limited availability of organic carbon (glucose) or inorganic N and P was studied in parallel. A positive correlation between surface water temperatures (-2 to 18 degreesC) an
The global methane (CH4) budget is becoming an increasingly important component for managing realistic pathways to mitigate climate change. This relevance, due to a shorter atmospheric lifetime and a stronger warming potential than carbon dioxide, is challenged by the still unexplained changes of atmospheric CH4 over the past decade. Emissions and concentrations of CH4 are continuing to increase,
BACKGROUND: Niemann-Pick disease type C (NP-C) is a rare neurovisceral disease characterised by progressive neurological degeneration, where the rate of neurological disease progression varies depending on age at neurological onset. We report longitudinal data on functional disease progression and safety observations in patients in the international NPC Registry who received continuous treatment w
Background: Dietary risks today constitute the largest proportion of disability-adjusted life years (DALYs) globally and in Sweden. An increasing number of people today consume highly processed foods high in saturated fat, refined sugar and salt and low in dietary fiber, vitamins and minerals. It is important that dietary trends over time are monitored to predict changes in disease risk. Methods:
BACKGROUND: The risk of spinal haematoma in patients receiving epidural catheters is estimated using routine coagulation tests, but guidelines are inconsistent in their recommendations on what to do when results indicate slight hypocoagulation. Postoperative patients are prone to thrombosis, and thromboelastometry has previously shown hypercoagulation in this setting. We aimed to better understand
Background: Out of Hospital Cardiac arrest (OHCA) survivors with ST elevation (STE) with or without shockable rhythms often benefit from coronary angiography (CAG) and, if indicated, percutaneous coronary intervention (PCI). However, the benefits of CAG and PCI in OHCA survivors with nonshockable rhythms (PEA/asystole) and no STE are debated. Methods: Using the International Cardiac Arrest Registr
Background: Warfarin-treated patients with a prolonged Prothrombin Time (PT) can have a normal rotational thromboelastometry (ROTEM) clotting time (CT). A previous in vitro study found that activated prothrombin complex concentrates (APCC) could reverse an albumin-induced coagulopathy monitored with ROTEM, but that prothrombin complex concentrates (PCC) could not. The aim of this study was to inve Background: Warfarin-treated patients with a prolonged Prothrombin Time (PT) can have a normal rotational thromboelastometry (ROTEM) clotting time (CT). A previous in vitro study found that activated prothrombin complex concentrates (APCC) could reverse an albumin-induced coagulopathy monitored with ROTEM, but that prothrombin complex concentrates (PCC) could not. The aim of this study was to in
Background: Treatment of newly diagnosed acute myeloid leukaemia (AML) is based on combination chemotherapy with cytarabine (ara-C) and anthracyclines. Five-year overall survival is below 30%, which has partly been attributed to cytarabine resistance. Preclinical data suggest that the addition of hydroxyurea potentiates cytarabine efficacy by increasing ara-C triphosphate (ara-CTP) levels through
Background: There are no evidence-based recommendations on the optimal time point to initiate non-vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in patients with atrial fibrillation. We aimed to investigate the efficacy and safety of early versus delayed initiation of NOAC in these patients. Methods: TIMING (Timing of Oral Anticoagulant Therapy in Acute Ischemic Strok
Background Underweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean body-mass index (BMI), which characterises its population distribution, and in the prevalences of a complete set of BMI categories for adults in all countries. Methods We analysed, with use of a consistent protocol, popul
